# FDA Inspection 1162640 - Altaire Pharmaceuticals, Inc. - February 11, 2022

Source: https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/05e433a1-838b-41ab-8c34-777aa069c24d
Source feed: FDA_Inspections

> FDA Inspection 1162640 for Altaire Pharmaceuticals, Inc. on February 11, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162640
- Company Name: Altaire Pharmaceuticals, Inc.
- Inspection Date: 2022-02-11
- Classification: No Action Indicated (NAI)
- Project Area: Monitoring of Marketed Animal Drugs, Feed, and Devices
- Product Type: Veterinary
- Office Name: Center for Veterinary Medicine

## Related Documents

- [FDA Inspection 1251507 - 2024-10-21](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/52c9de95-f12f-4b35-af57-5eadb622e6a6)
- [FDA Inspection 1251507 - 2024-10-21](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/b61fd512-2687-4ca8-8d73-1cfa85e5c680)
- [FDA Inspection 1162640 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/0c20c70c-b178-4306-8b90-55ba5c3ee376)
- [FDA Inspection 1089315 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/8e903be8-7abd-43af-8de9-de234d782298)
- [FDA Inspection 1089315 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/88456698-720e-4890-8fa6-8e45eb548627)

Company: https://www.keypedia.com/companies/altaire-pharmaceuticals-inc/1e892910-1e24-4697-87c3-61cc48735f49

Office: https://www.keypedia.com/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4